Methylphenidate decreases fat and carbohydrate intake in obese teenagers

16Citations
Citations of this article
86Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective Dopamine is a neurotransmitter that mediates the reward value of food. Methylphenidate (MPH) selectively binds and inhibits the dopamine transporter, thus increasing brain dopamine levels shortly after oral administration. This investigation studied whether a single dose of MPH decreases energy intake (EI) in obese teenagers compared to placebo (P). Methods This study used a single-blind, placebo-controlled, within subject design. Teenagers with body mass index (BMI) ≥95th percentile underwent two identical meal tests (P or MPH) after a 10 h fast in random order. Food was weighed before and after the meals, and EI was calculated as energy content/gram of consumed foods. Total and macronutrient EI (mean ± SD) were analyzed by Mann-Whitney U and Wilcoxon tests. Results Twenty-two subjects (15 females, 7 males) completed the study. Participants were 13.4 ± 2.2 years old and had BMI 34.9 ± 10.7 kg/mÂ. EI from fat (167 vs. 203 kcal, P = 0.03) and carbohydrates (311 vs. 389 kcal, P = 0.04) was decreased for MPH compared to P meals, with a trend in decreased total EI (545 vs. 663 kcal, P = 0.06). Conclusion A single dose of MPH decreases EI from fat and carbohydrates in obese adolescents. This effect underscores the importance of central dopamine signaling on eating behavior. Copyright © 2013 The Obesity Society.

References Powered by Scopus

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

622Citations
N/AReaders
Get full text

Is dopamine a physiologically relevant mediator of feeding behavior?

386Citations
N/AReaders
Get full text

Mechanism of action of methylphenidate: Insights from PET imaging studies

300Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Dopamine and glucose, obesity and reward deficiency syndrome

173Citations
N/AReaders
Get full text

Drug interventions for the treatment of obesity in children and adolescents

134Citations
N/AReaders
Get full text

Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric

39Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Danilovich, N., Mastrandrea, L. D., Cataldi, L., & Quattrin, T. (2014). Methylphenidate decreases fat and carbohydrate intake in obese teenagers. Obesity, 22(3), 781–785. https://doi.org/10.1002/oby.20574

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 37

73%

Researcher 8

16%

Professor / Associate Prof. 4

8%

Lecturer / Post doc 2

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 17

37%

Nursing and Health Professions 16

35%

Psychology 7

15%

Agricultural and Biological Sciences 6

13%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 44

Save time finding and organizing research with Mendeley

Sign up for free